Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$35.24 USD
-0.32 (-0.90%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $35.24 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Tandem Diabetes Care, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 468 | 617 | 624 | 485 | 176 |
Receivables | 106 | 115 | 111 | 82 | 47 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 158 | 111 | 69 | 64 | 49 |
Other Current Assets | 17 | 7 | 8 | 6 | 4 |
Total Current Assets | 748 | 850 | 812 | 637 | 276 |
Net Property & Equipment | 77 | 69 | 50 | 50 | 33 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 40 | 24 | 16 | 9 | 1 |
Total Assets | 953 | 1,053 | 905 | 716 | 326 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 50 | 56 | 28 | 18 | 18 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 56 | 48 | 61 | 39 | 36 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 72 | 48 | 34 | 38 | 39 |
Total Current Liabilities | 195 | 165 | 132 | 104 | 99 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 13 | 17 | 0 | 0 | 0 |
Convertible Debt | 285 | 283 | 281 | 203 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 32 | 24 | 35 | 27 | 18 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 639 | 613 | 472 | 350 | 131 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,264 | 1,171 | 1,068 | 1,025 | 820 |
Retained Earnings | -952 | -729 | -635 | -659 | -625 |
Other Equity | 1 | -2 | -1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 314 | 440 | 433 | 366 | 195 |
Total Liabilities & Shareholder's Equity | 953 | 1,053 | 905 | 716 | 326 |
Total Common Equity | 314 | 440 | 433 | 366 | 195 |
Shares Outstanding | 65.20 | 64.30 | 63.50 | 60.90 | 59.00 |
Book Value Per Share | 4.81 | 6.84 | 6.82 | 6.01 | 3.30 |
Fiscal Year End for Tandem Diabetes Care, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 468 | 498 | 507 | 520 |
Receivables | NA | 106 | 100 | 99 | 91 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 158 | 143 | 148 | 132 |
Other Current Assets | NA | 17 | 16 | 11 | 15 |
Total Current Assets | NA | 748 | 758 | 764 | 758 |
Net Property & Equipment | NA | 77 | 76 | 74 | 75 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 40 | 17 | 18 | 17 |
Total Assets | NA | 953 | 940 | 947 | 954 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 50 | 46 | 57 | 55 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 56 | 58 | 49 | 49 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 72 | 66 | 51 | 51 |
Total Current Liabilities | NA | 195 | 187 | 175 | 171 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 13 | 14 | 15 | 16 |
Convertible Debt | NA | 285 | 285 | 284 | 284 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 24 | 25 | 24 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 639 | 626 | 617 | 615 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,264 | 1,238 | 1,219 | 1,192 |
Retained Earnings | NA | -952 | -922 | -889 | -853 |
Other Equity | NA | 1 | -2 | -1 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 314 | 314 | 329 | 339 |
Total Liabilities & Shareholder's Equity | NA | 953 | 940 | 947 | 954 |
Total Common Equity | 0 | 314 | 314 | 329 | 339 |
Shares Outstanding | 65.60 | 65.20 | 65.20 | 65.00 | 64.60 |
Book Value Per Share | 0.00 | 4.81 | 4.82 | 5.07 | 5.24 |